We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
-3.61%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+478.73%
AUM
$1.54B
AUM Growth
-$91.2M
Cap. Flow
-$23.2M
Cap. Flow %
-1.5%
Top 10 Hldgs %
28.56%
Holding
300
New
9
Increased
79
Reduced
144
Closed
11

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.92M
2
WTW icon
Willis Towers Watson
WTW
+$5.84M
3
RTX icon
RTX Corp
RTX
+$4.24M
4
WBA
Walgreens Boots Alliance
WBA
+$2.98M
5
DVN icon
Devon Energy
DVN
+$2.46M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 15.07%
3 Financials 9.71%
4 Consumer Staples 8.13%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
76
Amgen
AMGN
$219B
$4.56M 0.3%
16,980
+3,060
+22% +$764K
TJX icon
77
TJX Companies
TJX
$179B
$4.34M 0.28%
48,877
-1,460
-3% -$129K
ADP icon
78
Automatic Data Processing
ADP
$109B
$4.29M 0.28%
17,825
TSCO icon
79
Tractor Supply
TSCO
$17.9B
$4.29M 0.28%
105,545
+2,570
+2% +$111K
LOW icon
80
Lowe's Companies
LOW
$122B
$4.26M 0.28%
20,511
-896
-4% -$202K
GWW icon
81
W.W. Grainger
GWW
$60.4B
$4.21M 0.27%
6,087
+2,565
+73% +$1.85M
LIN icon
82
Linde
LIN
$226B
$4.16M 0.27%
11,177
-590
-5% -$225K
SHM icon
83
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
$4M 0.26%
86,484
-235
-0.3% -$11K
IBB icon
84
iShares Biotechnology ETF
IBB
$9.53B
$3.97M 0.26%
32,434
-35
-0.1% -$4.45K
SPGI icon
85
S&P Global
SPGI
$119B
$3.92M 0.25%
10,719
+90
+0.8% +$35.4K
INTU icon
86
Intuit
INTU
$88.1B
$3.79M 0.25%
7,425
-675
-8% -$342K
AON icon
87
Aon
AON
$76.5B
$3.74M 0.24%
11,521
-205
-2% -$67.8K
TMUS icon
88
T-Mobile US
TMUS
$193B
$3.71M 0.24%
26,459
-435
-2% -$60.3K
SHW icon
89
Sherwin-Williams
SHW
$88.2B
$3.66M 0.24%
14,359
TFC icon
90
Truist Financial
TFC
$64.2B
$3.61M 0.23%
126,186
-200
-0.2% -$6.15K
OKE icon
91
Oneok
OKE
$55.4B
$3.6M 0.23%
56,779
-12
-0% -$783
BAC icon
92
Bank of America
BAC
$441B
$3.5M 0.23%
127,882
+11,840
+10% +$350K
ROP icon
93
Roper Technologies
ROP
$39.3B
$3.48M 0.23%
7,185
+85
+1% +$41.7K
VTV icon
94
Vanguard Morningstar Value ETF
VTV
$191B
$3.44M 0.22%
24,934
-1,585
-6% -$227K
BLK icon
95
Blackrock
BLK
$175B
$3.41M 0.22%
5,271
-191
-3% -$133K
NVS icon
96
Novartis
NVS
$293B
$3.36M 0.22%
32,962
+125
+0.4% +$12.7K
COP icon
97
ConocoPhillips
COP
$140B
$3.32M 0.22%
27,694
+175
+0.6% +$20.3K
AZO icon
98
AutoZone
AZO
$50.1B
$3.22M 0.21%
1,269
-19
-1% -$47.7K
GIS icon
99
General Mills
GIS
$19.3B
$3.21M 0.21%
50,179
-4,693
-9% -$332K
ABBV icon
100
AbbVie
ABBV
$431B
$3.11M 0.2%
20,878
-1,198
-5% -$176K

Similar funds

Chesley Taft & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Chesley Taft & Associates held 300 positions worth $1.54B, down 5.6% from $1.63B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Chesley Taft & Associates's Q3 2023 filing shows 9 new, 79 increased, 144 reduced and 11 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 12,375 shares worth $1.26M. The largest sale was CVS Health, an estimated $7.92M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Chesley Taft & Associates's largest Q3 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 12,375 shares worth $1.26M.
  • Chesley Taft & Associates added most to Palo Alto Networks in Q3 2023, an estimated $2.9M increase.
  • Chesley Taft & Associates's biggest Q3 2023 reduction was CVS Health, cutting an estimated $7.92M.
  • Chesley Taft & Associates fully exited Devon Energy in Q3 2023, selling an estimated $2.46M.
  • Chesley Taft & Associates's ten largest holdings make up 29% of its $1.54B portfolio in Q3 2023.
  • Chesley Taft & Associates opened 9 new positions and closed 11 in Q3 2023.
  • Chesley Taft & Associates's portfolio value fell 5.6% quarter-over-quarter to $1.54B.

Based on Chesley Taft & Associates's 13F filing for Q3 2023, filed 11 Oct 2023.